 |
|
|
| |
Treatment with Interferon- and Ribavirin-Free Regimens with Ledipasvir and Sofosbuvir Improves Patient-Reported Outcomes for Patients with Genotype 1 Chronic Hepatitis C: Results from the ION-1, 2 and 3 Clinical Trials
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Zobair M. Younossi1,2,7, Maria Stepanova2,7, Patrick Marcellin3, Nezam H. Afdhal4, Kris V. Kowdley5, Stefan Zeuzem6, Sharon L. Hunt7
1. Center for Liver Disease, Inova Fairfax Hospital, Falls Church, VA
2. Department of Medicine, Inova Fairfax Hospital, Falls Church, VA
3. Viral Hepatitis Research Unit , Hopital Beaujon, Clichy, France.
4. Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
5. Digestive Diseases Institute, Virginia Mason Clinic, Seattle, WA, United States.
6. Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany.
7. Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA
|
| |
|
|
|
|
|
